A GAS CHROMATOGRAPHIC DETERMINATION METHOD OF 5-CHLORO-7-IODO-8-QUINOLINOL AND ITS CONJUGATES IN BIOLOGICAL FLUIDSCHING TAN CHEN; SAMEJIMA K; TAMURA Z et al.1976; CHEM. PHARM. BULL.; JAP.; DA. 1976; VOL. 24; NO 1; PP. 97-101; BIBL. 13 REF.Article

Anticancer activity of the antibiotic clioquinolDING, Wei-Qun; BOLIN LIU; VAUGHT, Joshua L et al.Cancer research (Baltimore). 2005, Vol 65, Num 8, pp 3389-3395, issn 0008-5472, 7 p.Article

Clinical analysis of longstanding subacute myelo-optico-neuropathy: sequelae of clioquinol at 32 years after its banKONAGAYA, Masaaki; MATSUMOTO, Akihisa; MATSUOKA, Yukihiko et al.Journal of the neurological sciences. 2004, Vol 218, Num 1-2, pp 85-90, issn 0022-510X, 6 p.Article

SEPARATION AND QUANTIFICATION OF IODOCHLORHYDROXYQUIN AND ITS HOMOLOGUES BY THIN LAYER CHROMATOGRAPHY.VALLE OR; JIMENEZ D; LOPEZ SG et al.1978; J. CHROMATOGR. SCI.; U.S.A.; DA. 1978; VOL. 16; NO 4; PP. 162-165; BIBL. 12 REF.Article

Clioquinol Suppresses Cyclin D1 Gene Expression through Transcriptional and Post-transcriptional MechanismsJIE ZHENG; BENBROOK, Doris M; HAIJUN YU et al.Anticancer research. 2011, Vol 31, Num 9, pp 2739-2747, issn 0250-7005, 9 p.Article

Le cuivre, le fer et le zinc : Trois cibles thérapeutiques potentielles dans la maladie d'AlzheimerKOPPENAL, C; FINEFROCK, A. E; BUSH, A. I et al.Age & nutrition (Paris). 2004, Vol 15, Num 1, pp 4-7, issn 1158-0259, 4 p.Article

Clioquinol Independently Targets NF-κB and Lysosome Pathways in Human Cancer CellsHAIJUN YU; LOU, Jessica R; DING, Wei-Qun et al.Anticancer research. 2010, Vol 30, Num 6, pp 2087-2092, issn 0250-7005, 6 p.Article

Determination of 5-chloro-7-iodo-8-quinolinol (clioquinol) in plasma and tissues of hamsters by high-performance liquid chromatography and electrochemical detectionBONDIOLOTTI, G. P; POLLERA, C; PIROLA, R et al.Journal of chromatography. B. 2006, Vol 837, Num 1-2, pp 87-91, issn 1570-0232, 5 p.Article

Clioquinol and other hydroxyquinoline derivatives inhibit Aβ(1-42) oligomer assemblyLEVINE, Harry; QUNXING DING; WALKER, John A et al.Neuroscience letters. 2009, Vol 465, Num 1, pp 99-103, issn 0304-3940, 5 p.Article

IMPAIRMENT OF RECOGNITION MEMORY AND HIPPOCAMPAL LONG-TERM POTENTIATION AFTER ACUTE EXPOSURE TO CLIOQUINOLTAKEDA, A; TAKADA, S; ANDO, M et al.Neuroscience. 2010, Vol 171, Num 2, pp 443-450, issn 0306-4522, 8 p.Article

Persistance du risque neurologique du clioquinol = Neurologic risk of clioquinolDEVOIZE, J. L; CALMETTE, I; LAVARENNE, J et al.La Presse médicale (1983). 1983, Vol 12, Num 40, issn 0755-4982, 2532Article

A SIMPLE METHOD FOR THE DETERMINATION OF 5,7-DIIODOQUINOLIN-8-OL AND 5-CHLORO-7-IODOQUINOLIN-8-OL (CLIOQUINOL).SOLIMAN SA.1975; ANALYST; G.B.; DA. 1975; VOL. 100; NO 1195; PP. 696-702; BIBL. 21 REF.Article

Clioquinol induces DNA double-strand breaks, activation of ATM, and subsequent activation of p53 signalingKATSUYAMA, Masato; IWATA, Kazumi; IBI, Masakazu et al.Toxicology (Amsterdam). 2012, Vol 299, Num 1, pp 55-59, issn 0300-483X, 5 p.Article

Copper and clioquinol treatment in young APP transgenic and wild-type mice : effects on life expectancy, body weight, and metal-ion levelsSCHÄFER, Stephanie; PAJONK, Frank-Gerald; MULTHAUP, Gerd et al.Journal of molecular medicine (Berlin. Print). 2007, Vol 85, Num 4, pp 405-413, issn 0946-2716, 9 p.Article

Percutaneous absorption of iodochlorhydroxyquin in humansSTOHS, S. J; EZZEDEEN, F. W; ANDERSON, A. K et al.Journal of investigative dermatology. 1984, Vol 82, Num 2, pp 195-198, issn 0022-202XArticle

Clioquinol attenuates zinc-dependent β-cell death and the onset of insulitis and hyperglycemia associated with experimental type I diabetes in micePRIEL, Tsvia; ARICHA-TAMIR, Barak; SEKLER, Israel et al.European journal of pharmacology. 2007, Vol 565, Num 1-3, pp 232-239, issn 0014-2999, 8 p.Article

Cervical MRI of subacute myelo-optico-neuropathyKIMURA, E; HIRANO, T; YAMASHITA, S et al.Spinal cord. 2011, Vol 49, Num 2, pp 182-185, issn 1362-4393, 4 p.Article

Determination of the partition coefficient and acid dissociation constants of iodochlorhydroxyquin by an improved partition methodTANAKA, H; TAMURA, Z.Journal of pharmaceutical sciences. 1984, Vol 73, Num 11, pp 1647-1649, issn 0022-3549Article

Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Aβ amyloid deposition and toxicity in Alzheimer disease: A pilot phase 2 clinical trialRITCHIE, Craig W; BUSH, Ashley I; CARRINGTON, Darryl et al.Archives of neurology (Chicago). 2003, Vol 60, Num 12, pp 1685-1691, issn 0003-9942, 7 p.Article

LC of pharmaceutically important halogenated 8-hydroxyquinolines after precolumn derivatization with Pd (II)RIZK, M; BELAL, F; IBRAHIM, F et al.Journal of pharmaceutical and biomedical analysis. 2002, Vol 27, Num 5, pp 813-820, issn 0731-7085Article

Clioquinol effects on tissue chelatable zinc in miceNITZAN, Yuval B; SEKLER, Israel; FREDERICKSON, Christopher J et al.Journal of molecular medicine (Berlin. Print). 2003, Vol 81, Num 10, pp 637-644, issn 0946-2716, 8 p.Article

IN VITRO SENSITIVITY OF ENTAMOEBA HISTOLYTICA TO FURAZOLIDONE AND IODOCHLORHYDROXYQUIN, SEPARATE AND COMBINEDSARGEAUNT PG; LUMSDEN WHR.1976; TRANS. R. SOC. TROP. MED. HYG.; G.B.; DA. 1976; VOL. 70; NO 1; PP. 54-56; BIBL. 2 REF.Article

MYELO-NEUROPATHIE SENSITIVO-MOTRICE APRES ABSORPTION DE CHLOROIODOQUINONEFROISSART M; MORCAMP D; MIZON JP et al.1976; NOUV. PRESSE MED.; FR.; DA. 1976; VOL. 5; NO 13; PP. 863; BIBL. 5 REF.Article

NEUROTOXICITY OF HALOGENATED HYDROXYQUINOLINES CLINICAL ANALYSIS OF CASES REPORTED OUTSIDE JAPANBAUMGARTNER G; GAWEL MJ; KAESER HE et al.1979; J. NEUROL. NEUROSURG. PSYCHIATRY; GBR; DA. 1979; VOL. 42; NO 12; PP. 1073-1083; BIBL. 3 P.Article

SUBACUTE MYELO-OPTIC NEUROPATHY (SMON). FIRST NEURO-PATHOLOGICAL REPORT OUTSIDE JAPANRICOY JR; ORTEGA A; CABELLO A et al.1982; J. NEUROL. SCI.; ISSN 0022-510X; NLD; DA. 1982; VOL. 53; NO 2; PP. 241-251; BIBL. 22 REF.Article